Nanoviricides NNVC
NYSE NNVC
$1.01 -0.02 (-2.39%)
As of: Sep 10, 2026 · 3:59 PM EDT

Nanoviricides (NNVC) Interest Expenses (2013 - 2024)

Nanoviricides' (NNVC) quarterly Interest Expenses came in at $149.0 in Q4 2024, down 98.88% year-over-year from $13315.0 in Q1 2024, and down 98.88% quarter-over-quarter from $13315.0 in Q4 2023.

Analysis

Nanoviricides (NNVC) Interest Expenses (2013 - 2024) Analysis & Trends

Nanoviricides has disclosed Interest Expenses across 12 years of filings, most recently posting $149.0 for Q4 2024.

  • In Q4 2024, Interest Expenses fell 98.88% year-over-year to $149.0; the TTM figure through Jun 2025 stood at $149.0 (down 99.7% YoY), while the FY2025 annual figure was $149.0, down 99.7% from the prior year.
  • Interest Expenses came in at $149.0 for Q4 2024 at Nanoviricides, down from $13315.0 in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $44937.0 in Q1 2020 to a low of -$927.0 in Q2 2022.
  • Average Interest Expenses over 5 years is $15964.7, with a median of $4789.0 recorded in 2022.
  • Year-over-year, Interest Expenses tumbled 111.68% in 2022 and surged 14064.89% in 2023.
  • Over 5 years, Interest Expenses stood at $37293.0 in 2020, then slumped by 92.95% to $2631.0 in 2021, then plunged by 96.43% to $94.0 in 2022, then surged by 14064.89% to $13315.0 in 2023, then slumped by 98.88% to $149.0 in 2024.
  • Per Business Quant data, the three most recent Interest Expenses figures were $149.0 in Q4 2024, $13315.0 in Q4 2023, and $36493.0 in Q3 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Expense (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 673.00 Mn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 247.00 Mn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 11.00 Mn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn -1.00 Mn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 82.05 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn -
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn -
10 Nanoviricides 22.04 Mn 18.83 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 149.00
Dec 31, 2023 13,315.00
Sep 30, 2023 36,493.00
Dec 31, 2022 94.00
Sep 30, 2022 844.00
Jun 30, 2022 -927.00
Mar 31, 2022 4,789.00
Dec 31, 2021 2,631.00
Sep 30, 2021 891.00
Jun 30, 2021 7,934.00
Mar 31, 2021 2,516.00
Dec 31, 2020 37,293.00
Sep 30, 2020 43,909.00
Jun 30, 2020 44,602.00
Mar 31, 2020 44,937.00
Dec 31, 2019 4,131.00
Jun 30, 2018 314,726.00
Dec 31, 2017 60,275.00
Sep 30, 2017 125,000.00
Jun 30, 2017 125,000.00